Reporting owner · CIK 0002069522

Duffy Sean P.

SEC Form 4 history across 1 companies, 20 transactions and 4 filings.

CEOChief Executive OfficerOmada Health, Inc.
Open-market transaction mix0% buys0 buys · 8 sales

Available history · Sep 01, 2026 – Oct 01, 2026

Filings4Form 4 records
Buying$00 purchases
Selling$1.2M8 sales
Net value−$1.2MBuys minus sells · disclosed values

Latest insider transactions

Form 4 filings from available history.
Duffy Sean P. transactions · 20 per page
CompanyInsiderActivityDisclosed valueFiled (ET)
OMDAOmada Health, Inc.
Duffy Sean P.CEOM · exercise10b5-1 detectedDerivative securitySEC filing ↗$0View disclosure →
OMDAOmada Health, Inc.
Duffy Sean P.CEOM · exercise10b5-1 detectedDerivative securitySEC filing ↗$0View disclosure →
OMDAOmada Health, Inc.
Duffy Sean P.CEOS · sale10b5-1 detectedSEC filing ↗-$90.1kView disclosure →
OMDAOmada Health, Inc.
Duffy Sean P.CEOS · sale10b5-1 detectedSEC filing ↗-$266kView disclosure →
OMDAOmada Health, Inc.
Duffy Sean P.CEOM · exercise10b5-1 detectedSEC filing ↗$35.7kView disclosure →
OMDAOmada Health, Inc.
Duffy Sean P.CEOM · exercise10b5-1 detectedSEC filing ↗$75.3kView disclosure →
OMDAOmada Health, Inc.
Duffy Sean P.CEOS · sale10b5-1 detectedSEC filing ↗-$31.6kView disclosure →
OMDAOmada Health, Inc.
Duffy Sean P.CEOS · sale10b5-1 detectedSEC filing ↗-$295kView disclosure →
OMDAOmada Health, Inc.
Duffy Sean P.CEOF · withholdingSEC filing ↗-$100kView disclosure →
OMDAOmada Health, Inc.
Duffy Sean P.CEOM · exercise10b5-1 detectedDerivative securitySEC filing ↗$0View disclosure →
OMDAOmada Health, Inc.
Duffy Sean P.CEOM · exercise10b5-1 detectedDerivative securitySEC filing ↗$0View disclosure →
OMDAOmada Health, Inc.
Duffy Sean P.CEOM · exercise10b5-1 detectedDerivative securitySEC filing ↗$0View disclosure →
OMDAOmada Health, Inc.
Duffy Sean P.CEOF · withholding10b5-1 detectedSEC filing ↗-$225kView disclosure →
OMDAOmada Health, Inc.
Duffy Sean P.CEOS · sale10b5-1 detectedSEC filing ↗-$89.6kView disclosure →
OMDAOmada Health, Inc.
Duffy Sean P.CEOS · sale10b5-1 detectedSEC filing ↗-$114kView disclosure →
OMDAOmada Health, Inc.
Duffy Sean P.CEOS · sale10b5-1 detectedSEC filing ↗-$135kView disclosure →
OMDAOmada Health, Inc.
Duffy Sean P.CEOS · sale10b5-1 detectedSEC filing ↗-$169kView disclosure →
OMDAOmada Health, Inc.
Duffy Sean P.CEOM · exercise10b5-1 detectedSEC filing ↗$39.6kView disclosure →
OMDAOmada Health, Inc.
Duffy Sean P.CEOM · exercise10b5-1 detectedSEC filing ↗$35.7kView disclosure →
OMDAOmada Health, Inc.
Duffy Sean P.CEOM · exercise10b5-1 detectedSEC filing ↗$75.3kView disclosure →

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

sale at Omada Health, Inc. on Oct 01, 2026 valued at $90,163.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Omada Health, Inc. on Oct 01, 2026 valued at $90,163.

Review SEC filing

Monthly open-market activity

Last 2 reported months · purchases and sales

View exact monthly values
Monthly open-market source values
MonthPurchasesSalesBuy valueSale valueNet value
Sep 202606$0.00$836,661.99-$836,661.99
Oct 202602$0.00$356,915.14-$356,915.14

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size$149.2K
Median P/S size$125K
Direct20
Indirect0
Oct 01, 2026exercise

Associated companies

Companies in the disclosed reporting history

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
No open-market purchases in available history

A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

15 observations · Sep 1, 2026 – Oct 1, 2026. Window ends at the latest available report, not today.

Selected observation · Oct 1, 2026382,594 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Sep 1, 2026424,805Sep 3, 2026View transaction
Sep 1, 2026429,119Sep 3, 2026View transaction
Sep 1, 2026433,433Sep 3, 2026View transaction
Sep 1, 2026426,089Sep 3, 2026View transaction
Sep 1, 2026420,489Sep 3, 2026View transaction
Sep 1, 2026415,556Sep 3, 2026View transaction
Sep 1, 2026411,861Sep 3, 2026View transaction
Sep 1, 2026401,976Sep 3, 2026View transaction
Sep 5, 2026397,554Sep 9, 2026View transaction
Sep 10, 2026383,994Sep 14, 2026View transaction
Sep 10, 2026382,594Sep 14, 2026View transaction
Oct 1, 2026395,538Oct 5, 2026View transaction
Oct 1, 2026399,852Oct 5, 2026View transaction
Oct 1, 2026386,908Oct 5, 2026View transaction
Oct 1, 2026382,594Oct 5, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Duffy Sean P. Insider Activity FAQ

SEC Form 4 context

Who is Duffy Sean P.?

Duffy Sean P. is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002069522.

Which companies has Duffy Sean P. reported transactions for?

Omada Health, Inc.

When was Duffy Sean P.'s latest insider buy?

No open-market insider purchase is available for this period.

When was Duffy Sean P.'s latest insider sale?

sale at Omada Health, Inc. on Oct 01, 2026 valued at $90,163.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.